Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
Starting from its 2026 valuation, what market size is the Poc Hba1C Testing Market expected to reach by 2030?
The poc hba1c testing market size has experienced rapid growth in recent years. It is expected to expand from $1.02 billion in 2025 to $1.14 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.9%. The market’s development in the historic period can be attributed to the rising global prevalence of diabetes, increased clinical reliance on long-term glucose monitoring, the expansion of outpatient diagnostic services, growing awareness of early diabetes diagnosis, and the availability of compact diagnostic instruments.
The market size for poc hba1c testing is anticipated to undergo significant expansion over the next few years. This market is expected to reach $1.76 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.4%. The increase during the forecast period can be attributed to the rising adoption of decentralized diagnostics, an escalating demand for home care testing solutions, the expansion of digital diabetes management programs, an increased focus on preventive healthcare, and growing investments in rapid diagnostic technologies. Prominent trends within the forecast period include the increasing uptake of rapid point-of-care hba1c devices, a growing utilization of portable and handheld testing systems, a surging demand for home-based diabetes monitoring, the broadening of integrated poc diagnostic platforms, and an enhanced emphasis on test accuracy and standardization.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6833&type=smp
What Drivers Are Driving Adoption Within The Poc Hba1C Testing Market?
The rising incidence of diabetes is propelling the expansion of the point-of-care (POC) HbA1C testing market moving ahead. This chronic metabolic condition is marked by high blood glucose, necessitating ongoing surveillance to avert severe complications like neuropathy, cardiovascular ailments, and renal dysfunction. Globally, the increase in diabetes diagnoses stems from factors including inactive lifestyles, poor eating habits, obesity, and an aging demographic. The growing prevalence of diabetes bolsters the point-of-care (POC) HbA1C testing market by escalating the need for rapid, user-friendly, and precise glycemic control evaluations across clinics, pharmacies, and home-based care, thereby facilitating prompt therapeutic choices. As an illustration, the International Diabetes Federation, a health organization based in Belgium, reported that in 2025, in 2024, approximately 589 million adults aged 20-79 had diabetes, with this figure anticipated to climb to 853 million by 2050, and over 4 in 5 of these adults living in low and middle-income nations. Consequently, the expanding prevalence of diabetes is a key factor propelling the growth of the point-of-care (POC) HbA1C testing market.
How Is The Poc Hba1C Testing Market Organized Into Various Segments?
The poc hba1c testing market covered in this report is segmented –
1) By Type of Product: Instruments, Consumables
2) By Technology: Ion-Exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Immunoassay, Other Technologies
3) By End User: Hospitals, Physician Office Or Outpatient Center, Home Care, Other End Users
Subsegments:
1) By Instruments: Handheld HbA1c Testing Devices, Portable HbA1c Analyzers, Desktop HbA1c Testing Systems, Integrated Point Of Care Testing Systems
2) By Consumables: Test Strips, Control Solutions, Reagents, Calibration Solutions, Sample Collection Devices
Which Competitive Trends Are Impacting The Structure Of The Poc Hba1C Testing Market?
Leading companies in the point-of-care (POC) HbA1c testing market are progressively integrating built-in internal verification systems to assure test accuracy, decrease the likelihood of errors, and enhance trust in near-patient diagnostics. These self-check mechanisms consistently monitor environmental factors, sample integrity, and assay performance during every test to avoid erroneous results or sample loss. For example, in July 2024, Siemens Healthineers, a Germany-based medical technology company, launched its advanced point-of-care Atellica DCA Analyser. The Atellica DCA Analyser employs its exclusive Auto-Checks Technology, which executes a range of internal calibrations and verifications throughout the testing process, encompassing environmental calibration, airflow and thermal verification, sample volume and integrity checks, optical clarity, and precision assessments. This automated self-monitoring guarantees that each HbA1c result, provided in just 4–5 minutes, is of laboratory-equivalent quality, while also reducing the need for continuous operator supervision. By embedding these self-checks, the Atellica DCA helps minimize pre-analytical errors, boost confidence in results, and support the broader implementation of point of care (POC) testing in settings where laboratory infrastructure is limited.
Who Are The Primary Competitors In The Global Poc Hba1C Testing Market?
Major companies operating in the poc hba1c testing market are F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Bio-Rad Laboratories Inc, Menarini Group, Danaher Corporation, Tosoh Bioscience Inc, ARKRAY Inc, i-SENS Inc, Abbott Laboratories, Trinity Biotech plc, Aina Blood Monitoring System, Getein Biotech Inc, Sugentech Inc, Alere Inc, EKF Diagnostics, HemoCue, PTS Diagnostics, Osang Healthcare, Ortho Clinical Diagnostics, Ascensia, Platinum Equity (LifeScan), Becton Dickinson and Company, Kainico Ltd, Evia Medical Technologies, Agamatrix Inc, Bionime Corporation
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-global-market-report
Which Regions Are Poised For Strategic Growth In The Poc Hba1C Testing Market?
North America was the largest region in the POC HbA1C testing market in 2025. Africa is expected to be the fastest-growing region in the forecast- period. The regions covered in the poc hba1c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Poc Hba1C Testing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=6833&type=smp
Browse Through More Reports Similar to the Global Poc Hba1C Testing Market 2026, By The Business Research Company
Hemoglobin A1C Hba1C Testing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report
Poc Cholesterol Test Market 2026
https://www.thebusinessresearchcompany.com/report/poc-cholesterol-test-market
Hemoglobin A1C Testing Devices Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company